Develops and commercializes innovative breast implant technologies and medical aesthetics products, focusing on safety and patient outcomes.
Establishment Labs Holdings Inc. is a leading medical technology company specializing in the design, manufacture, and distribution of innovative medical devices for aesthetic and reconstructive plastic surgery. At the forefront of their offerings are silicone gel-filled breast implants marketed under the Motiva Implants brand name. These implants include advanced options like the Motiva Ergonomix and Motiva Ergonomix2, which feature gravity-sensitive round soft silicone-gel-filled designs, catering to the diverse needs of patients and surgeons alike.
In addition to their breast implant portfolio, Establishment Labs develops and distributes the Motiva Flora Tissue Expander, designed specifically for breast tissue expansion procedures. The company also plays a pivotal role in the field of autologous adipose tissue harvesting and redistribution through its distribution of the Puregraft line of products. These innovations underscore Establishment Labs' commitment to enhancing surgical outcomes and patient satisfaction across global markets.
Founded in 2004 and headquartered in Alajuela, Costa Rica, Establishment Labs operates through a network of exclusive distributors and a dedicated direct sales force across Europe, Latin America, the Asia-Pacific region, and beyond. With a steadfast dedication to technological advancement and clinical excellence, Establishment Labs continues to shape the future of aesthetic and reconstructive surgery worldwide.